17 more virus deaths as 72 patients admitted in ICU

369 more patients have recovered from the disease.

In Summary

•The country's fatalities have risen to 1,469 after another 17 patents succumbed to the disease.

•Kagwe said that there are 1,282  patients currently admitted in various hospitals across the country. Another, 8,405 patients are on the home-based care programme.

Health CS Mutahi Kagwe
Health CS Mutahi Kagwe

Kenya on Monday recorded 302 new cases of Covid-19, bringing the country's case load to 83,618, Health CS Mutahi Kagwe has said.

The CS in a statement confirmed that this was from a sample size of 3,038 recording a positivity rate of 9.9 per cent.

The cumulative tests stand at 888,971.

 

The country's fatalities have risen to 1,469 after another 17 patients succumbed to the disease.

Kagwe said that there are 1,282  patients currently admitted in various hospitals across the country. Another, 8,405 patients are on the home-based care programme.

A total of 72 patients are in ICU, out of which 47 are on ventilatory support.

Also, 92 patients are separately on supplementary oxygen, out of which 72 are in general wards and 20 in the HDU.

Meanwhile, 369 patients have recovered from the disease out of which 287 were from the Homebased care program while 82 were discharged from various health facilities.

Kenya's recoveries now stand at 55,344.

From the new cases reported on Monday, 286 are Kenyans while 16 are foreigners.

 

In terms of gender, 191 are males while 111 are females and the youngest in a one-year-old child and the oldest is 83.

Nairobi leads with 134 cases, Kajiado 26, Kisumu 17, Kitui 16, Marsabit 16, Nyeri 16, Mombasa 13, Meru 13, Machakos 13, Nakuru 9, Kiambu 9, Uasin Gishu 8, Embu 2, Busia 2.

Kilifi, Laikipia, Murang'a, Kakamega, Makueni, Samburu, Tana River and Kericho recorded single cases each.

Kagwe said the government will collaborate with researchers from South Korea, India, Singapore and China in the trials for a vaccine.

Kenya is already among seven countries participating in the Astra-Zeneca and Oxford University research. 

"It is expected that across all this countries, there will be 60,000 participants in the trails before the end of the year," the CS said.